Renu Meena

Medical Content Writer · Bachelor of Pharmacy (B.Pharm)

Registration: 55661 4 years of experience

Renu Meena is a Medical Content Writer with a strong pharmacy-practice background and a B.Pharm from Rajasthan University of Health Sciences (RUHS), Jaipur. With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

Specialisation

  • Medical & Pharmaceutical Content Writing (products + blogs + patient education)
  • Disease Education and disease management guide
  • Medication Use Content (how to use, safety, precautions, adherence support)
  • Drug Safety / Pharmacovigilance content
  • Regulatory-aligned writing, including familiarity with: ICH guidelines, GVP modules, ICD-10 and ICD-11, CIOMS working groups, Regulatory reporting obligations, Patient safety analysis activities
  • Content types: evidence-based articles, educational materials, compliance-friendly health content

Experience

  • Started career as a Pharmacist, building hands-on expertise in:

    • Medication management

    • Patient counselling

    • Practical pharmaceutical care workflows

  • Transitioned into Medical Writing / Disease Content / Medical Affairs, contributing to:

    • Product/medicine information content

    • Disease education and management guides

    • Drug safety and compliance-focused health content

  • Known for detail orientation, research strength, and staying updated with pharmacology and healthcare advancements

LinkedIn profile

Written by this author

FDA Approves Inavolisib with Palbociclib and Fulvestrant for Advanced Breast Cancer
Cancer Medicine

FDA Approves Inavolisib with Palbociclib and Fulvestrant for Advanced Breast Cancer

On October 10, 2024, the Food and Drug Administration (FDA) approved Inavolisib, in combination with Palbociclib and Fulvestrant, for adults with advanced breast cancer that meets specific criteria. This approval is essential for patients who have: Endocrine-resistant breast cancer PIK3CA-mutated tumors Hormone receptor (HR)-positive status HER2-negative status Locally advanced or metastatic disease, as identified by an FDA-approved […]

  • 25/06/2024
Premature Ejaculation Unveiled: Symptoms, Causes, and Treatments
Erectile Dysfunction

Premature Ejaculation Unveiled: Symptoms, Causes, and Treatments

Premature ejaculation (PE) is the most common sexual problem in men, affecting about 20-30%  men worldwide. It can impact relationships, causing stress for the man and his partner, but understanding its symptoms, causes, dosage, and treatments may help a person suffering from PE. You may feel self-conscious if you have experienced Premature ejaculation, but you’re not […]

  • 05/06/2024
Beyond Weight Loss: The Multifaceted Impact of GLP-1 Drugs

Beyond Weight Loss: The Multifaceted Impact of GLP-1 Drugs

In the field of pharmaceuticals, innovation can arise from unexpected origins. Take the Gila monster, a lethargic North American lizard with striking black and orange scales and a venomous bite. Despite spending most of its time underground and having infrequent eating habits, this creature has incidentally led to a breakthrough in modern medicine: the development […]

  • 10/04/2024
Top 10 Best ED Pills to Consider Today
Erectile Dysfunction

Top 10 Best ED Pills to Consider Today

Erectile dysfunction (ED) is the most common sex issue that affects 30 million men in the United States; the National Institute of Health NIH states that a 2018 review estimated ED affects about a third of men during sexual intercourse, creating challenges in maintaining and achieving an erection that is sufficient for sexual activity. Fortunately, […]

  • 17/03/2024
Ways in which PrEP works to prevent HIV!
Generic Drugs

Ways in which PrEP works to prevent HIV!

PrEP suggests opting for anti-HIV medicine to reduce the risk of infection. One should know that the medicine can easily help in adding safety to the individual from HIV or various other diseases that might easily affect the body. PrEP Pre-exposure prophylaxis is a medication that helps prevent the infection from being transmitted into the […]

  • 12/02/2024
Medicine Import Guidelines Of Greece For Personal Use
Medicine Import Guidelines

Medicine Import Guidelines Of Greece For Personal Use

Importing medicines for personal use to Greece is reassuring for people with special medical needs. However, this process must be carried out with care. Legality and safety are ensured through approval rules established by the National Agency for Medical Products, EOF, and the European Union, EU. A valid prescription from a licensed medical professional is […]

  • 30/01/2024
Medicine import guidelines for the United States for personal use
Medicine Import Guidelines

Medicine import guidelines for the United States for personal use

Importing medicine for personal use into the United States is a viable option for individuals pursuing medications that may not be readily available locally. Under the Personal Importation Policy (PIP), the Food and Drug Administration (FDA) lets foreigners bring in 90 days’ worth of prescription and over-the-counter drugs. In this guide, we’ll show you the […]

  • 12/01/2024
Medicine Import Guidelines Of Netherland For Personal Use
Medicine Import Guidelines

Medicine Import Guidelines Of Netherland For Personal Use

In today’s digital era, importing medicines online has become much easier. Importing medication into the Netherlands must comply strictly with applicable laws. The import of unlicensed drugs is prohibited, so it is essential to obtain a prescription from a Doctor. Understanding and complying with these regulations will allow people to import drugs to the Netherlands […]

  • 10/12/2023